Literature DB >> 27898198

AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.

Zhen Gooi1, Jeremy Richmon2, Nishant Agrawal1, Elizabeth Blair1, Louis Portugal1, Everett Vokes3, Tanguy Seiwert3, Jonas de Souza3, Vassiliki Saloura3, Daniel Haraf4, David Goldenberg5, Jason Chan6.   

Abstract

This article is a continuation of the "Do You Know Your Guidelines" series, an initiative of the American Head and Neck Society's Education Committee to increase awareness of current best practices pertaining to head and neck cancer. The National Comprehensive Cancer Network guidelines for the management of nasopharyngeal cancer are reviewed here in a systematic fashion. These guidelines outline the workup, treatment and surveillance of patients with nasopharyngeal cancer.
© 2016 Wiley Periodicals, Inc. Head Neck 39: 201-205, 2017. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Epstein-Barr virus; National Comprehensive Cancer Network (NCCN) guidelines; fiber-optic examination; fine-needle aspiration; nasopharyngeal cancer

Mesh:

Year:  2016        PMID: 27898198     DOI: 10.1002/hed.24635

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Editorial: Advances in the Diagnosis and Treatment of Skull Base Tumours.

Authors:  Eoin F Cleere; Aviram Mizrachi; Marc A Cohen; James Paul O'Neill
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

2.  Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck Carcinoma.

Authors:  Ryusuke Hori; Shogo Shinohara; Tsuyoshi Kojima; Hiroki Kagoshima; Morimasa Kitamura; Ichiro Tateya; Hisanobu Tamaki; Yohei Kumabe; Ryo Asato; Hiroyuki Harada; Yoshiharu Kitani; Takashi Tsujimura; Keigo Honda; Kazuyuki Ichimaru; Koichi Omori
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

3.  TBX3 knockdown suppresses the proliferation of hypopharyngeal carcinoma FaDu cells by inducing G1/S cell cycle arrest and apoptosis.

Authors:  Yongjiu Huang; Hongmei Zhu; Xiaohui Ji; Yin Chen; Yanhui Zhang; Ruofei Huang; Jin Xie; Pin Dong
Journal:  Oncol Lett       Date:  2019-11-13       Impact factor: 2.967

4.  Geographical disparities in the prognosis of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a large institution-based cohort study from an endemic area.

Authors:  Si-Ting Lin; Dong-Fang Meng; Qi Yang; Wei Wang; Li-Xia Peng; Li-Sheng Zheng; Yuan-Yuan Qiang; Yan Mei; Liang Xu; Chang-Zhi Li; Xing-Si Peng; Hao Hu; Yan-Hong Lang; Zhi-Jie Liu; Ming-Dian Wang; Hai-Feng Li; Bi-Jun Huang; Chao-Nan Qian; Rui Sun
Journal:  BMJ Open       Date:  2020-11-10       Impact factor: 2.692

5.  Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells.

Authors:  Ming-Ying Lan; Yen-Bin Hsu; Ming-Chin Lan; Jyh-Ping Chen; Yu-Jen Lu
Journal:  Int J Nanomedicine       Date:  2020-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.